Cannell & Spears’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
OAG
PCM
Cannell & Spears's CELG Position: Q1 2019 in Review
Cannell & Spears sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 191,859 shares — an estimated $12.3M sold.
Cannell & Spears first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $28.1M in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.
- Cannell & Spears reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
- Cannell & Spears sold 191,859 Celgene Corp shares in Q1 2019, an estimated $12.3M.
- Cannell & Spears first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
- Cannell & Spears's Celgene Corp position peaked at $28.1M in Q3 2017.
- 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.
Based on Cannell & Spears's 13F filing for Q1 2019, filed 14 May 2019.